PROGETTO SMA-TCHING

Progetto FRRB ID 4956734 - Spinal muscular atrophy translating customized health innovations to newborn and grown-up patients (SMA-TCHING)

Dati del progetto

Principal Investigator

Dr.ssa Silvia Bonanno

Ente ospitante

Fondazione IRCCS Istituto Neurologico "C. Besta"

Area Tematica

Neurologia

Data di inizio Progetto

24/02/2025

Data di fine Progetto

23/02/2028

Importo assegnato

500.000,00 €

Tipo Progetto

Individuale

PROJECT AIM

Spinal muscular atrophy (SMA) natural history is changing with the advent of disease-modifying drugs (DMDs). However, SMA patients’ response to DMDs is partial and highly variable, with marked benefits in the precocious treatments. This project aims to:

•Discover non-invasive BMs, providing predictive, prognostic and pharmacodynamic information, to promptly address patients to the most suited therapeutic intervention.

•Identify specific SMA patients’ subclasses-omic signatures, to disclose tailored therapeutic targets of innovative treatments complementary to DMDs.

•Test the efficacy of a novel nanotechnology-based treatment targeting atrophy in a patient specific skeletal muscle in vitro model to overcome muscle impairment and contribute to MN functionality.